Cardiac Intensive Care E-Book
The new edition of Cardiac Intensive Care—the only textbook dedicated to cardiac intensive care medicine—chronicles the progress made in the diagnosis, assessment, and treatment of patients with critical cardiac illness. Editors Allen Jeremias, MD, MSc and David L. Brown, MD present the landmark discoveries, greater understanding of syndromes, and technological advancements that have helped make clinical cardiology a progressive and interventional field. You’ll get coverage of the plethora of noncoronary diseases in the CICU, as well as a complete compendium of up-to-date pharmacologic agents. The new full-color design and layout and nine new chapters give you the latest theoretical, technical, diagnostic, and therapeutic advances in an accessible and visually appealing format.
What people are saying - Write a review
We haven't found any reviews in the usual places.
SECTION II Scientific Foundation of CardiacIntensive Care
SECTION III Coronary Artery Disease
Diagnosis and Management
SECTION V Pharmacologic Agents in the CICU
Indications andTechnical Considerations
APPENDICES American College of CardiologyAmerican Heart Association Management Guidelines
ACC/AHA ACE inhibitor acute coronary syndromes acute myocardial infarction agents angiography angioplasty anticoagulation aortic dissection arrhythmias aspirin associated bleeding block blood pressure cardiac output cardiac tamponade cardiogenic shock Cardiovasc cardiovascular catheter chest chronic CICU Circulation Clin clinical clopidogrel Coll Cardiol complications coronary artery decrease diagnosis diastolic dose drugs dysfunction echocardiography edema effects embolism Engl evaluation factor fibrillation fibrinolytic function guidelines heart disease heart failure hemodynamic heparin hypotension IIb/IIIa implantation increase intravenous ischemia ischemic left ventricular lesions lung mitral regurgitation mortality occur ofthe oxygen pacemaker pacing patients with acute percutaneous coronary intervention pericardial physicians plaque plasminogen activator platelet pressure-volume primary PCI pulmonary artery pulmonary hypertension randomized receptor reduced reinfarction renal reperfusion revascularization right ventricular risk rupture ST segment elevation STEMI stenosis stent stroke systolic t-PA tachycardia tamponade thrombin thrombolytic therapy thrombosis thrombus tion tissue treatment trial troponin valve vascular venous ventricle versus